biomedical research

A sign at the 23andMe headquarters
Leadership

These are the people who want to buy 23andMe

By
April 1, 2025
Cancer vaccination, conceptual illustration
Health

Personalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial shows

By
February 7, 2025
Scientists working in a lab
Finance

Investors are plunking billions of dollars into AI-focused biopharma companies—a more than 300% increase from 2023

By Healthcare Brew and Maia Anderson
January 31, 2025
Man exhales smoke while legally smoking weed with a vape pen
Mind

The truth about cannabis: Researchers from largest study on its effects on the brain have a warning for young adults

By
January 28, 2025
Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication in the works that could be approved by the FDA as early as 2026, CEO Dave Ricks told Bloomberg TV on Jan. 13, 2025.
Health

Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says

By
January 22, 2025
As part of its quest to “discover the science of humanity,” the Truveta Genome Project will gather the de-identified genetic data of tens of millions of consented volunteers, health data startup Truveta announced Jan. 13, 2025.
Health

Pharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers

By
January 16, 2025
Moderna is recruiting adult participants for Nova 301, its Phase 3 clinical trial evaluating an investigational norovirus vaccine called mRNA-1403.
Health

Moderna says it’s ‘one step closer’ to a norovirus vaccine as the virus spreads across the U.S.

By
January 11, 2025
Lynparza (olaparib), a product of Fortune 500 pharmaceutical firm Merck and Fortune 500 Europe company AstraZeneca, showed meaningful improvements in overall survival in people with germline BRCA-mutated (gBRCAm), HER2-negative high-risk early breast cancer, 2024 clinical trial data suggest.
Health

Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows

By
December 20, 2024
Existing research has tied sedentary behavior to a slew of health problems in both children and adults. But a 2024 study suggests exercise may not be enough to undo the cardiovascular damage of too much sitting.
Health

Sitting too much is a danger not even exercise can undo. Here are 5 tips to move more

By
November 18, 2024
Both hospital and residential sinks are breeding grounds for pathogens capable of causing illnesses including pneumonia, wound infections, and Legionnaires’ disease, according to researchers at Flinders University in South Australia.
Health

Your sink is a breeding ground for bacteria that cause pneumonia and Legionnaires’ disease. How to keep it clean

By
September 6, 2024
SARS-CoV-2, the coronavirus that causes COVID-19, can cause ocular infection by breaching the blood-retinal barrier, layers of cells that shield the retina, the part of your eye that senses light, from microbial pathogens.
Health

COVID can seriously damage your vision, even if you didn’t have symptoms, new study says. Experts say to watch for these signs

By
June 11, 2024
People living with obesity reap the greatest health benefits from being physically active in the evening, according to a new Australian study.
Life

This is the best time of day to exercise for people living with obesity, new study shows

By
May 18, 2024
Good DeepMind CEO Demis Hassabis and John Jumper, the scientist who heads the company's protein structure team, accepting a Breakthrough Pirze for their work on AlphaFold 2.
Tech

Google DeepMind and Isomorphic Labs reveal AI able to predict large swathes of molecular biology

By
May 8, 2024
In one study reviewed by Stanford postdoctoral fellow Renske Lok, PhD, and her colleagues, women secreted the sleep hormone melatonin earlier in the evening than men.
Health

Do men really sleep better than women? Experts explain

By
May 2, 2024
A scientist in a lab coat peers into a microscope in a lab.
Newsletters

AI for drug discovery draws a $1 billion launch—and a lot of hope

By
April 25, 2024

Most Popular